8741/16820US=1-A / Farmacologia
Phillips MA, Stanley SL Jr. Quimioterapia das infecções por protozoários: amebíase, giardíase, tricomoníase, leishmaniose e outras infecções por protozoários. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 941-61. ISBN 85-6330801-6.

AMEBIASE; GIARDIASE; TRICOMONIASE; TOXOPLASMOSE; CRIPTOSPORIDIOSE; TRIPANOSSOMIASE; LEISHMANIOSE; ANFOTERICINA; CLOROQUINA; EFLORNITINA; MELARSOPROL; METRONIDAZOL; MILTEFOSINA; NIFURTIMOX; NITAZOXANIDA; PAROMOMICINA; PENTAMIDINA; ESTIBOGLICONATO DE SODIO; SURAMINA

8742/16820US=23-E / Câncer
Richiardi L, Maule MM. Survivors of germ-cell testicular cancer: increased risk of second primary tumors. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 181-91. ISBN 978-90-481-2917-1.

GERMES; CELULAS DE CANCER TESTICULAR; TUMOR PRIMARIO

8743/16820US=23-E / Câncer
Svatek RS, Lotan Y. Urothelial bladder cancer: screening with urine-based tumor markers. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 197-209. ISBN 978-90-481-2917-1.

CANCER DE BEXIGA UROTELIAL; TRIAGEM HEMATURIA; URINA BASEADO MARCADORES TUMORAIS

8744/16820US=23-E / Câncer
Mowla SJ, Jafarnejad SM, Atlasi Y. Detection of OCT-4 in bladder cancer: role of cancer stem cell. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 211-26. ISBN 978-90-481-2917-1.

DETECCAO DE OCT-4; CANCER DE BEXIGA; PAPEL DE CELULA-TRONCO DO CANCER

8745/16820US=1-A / Farmacologia
Petri WA Jr. Sulfonamidas, sulfametoxazol-trimetoprima, quinolonas e agentes para infecções do trato urinário. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 999-1012. ISBN 85-6330801-6.

SULFONAMIDAS; SULFONAMIDAS. PROPRIEDADES FARMACOLOGICAS; SULFAMETOXAZOL-TRIMETOPRIMA; QUINOLONA; INFECCOES DO TRATO URINARIO. TRATAMENTO

8746/16820US=23-E / Câncer
Baker AC, Grizzle WE, Chhieng D. Uterine cervical glandular lesions: differentiation using immunohistochemistry of mucins. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 231-42. ISBN 978-90-481-2917-1.

CERVICO-UTERINO; LESOES GLANDULARES; IMUNOHISTOQUIMICA DAS MUCINAS

8747/16820US=23-E / Câncer
Baker AC, Grizzle WE, Chhieng D. Uterine cervical glandular lesions: differentiation using immunohistochemistry of mucins. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 243-53. ISBN 978-90-481-2917-1.

CERVICO-UTERINO; LESOES GLANDULARES; IMUNOHISTOQUIMICA DE MUCINAS

8748/16820US=1-A / Farmacologia
Petri WA Jr. Penicilinas, cefalosporinas e outros antibióticos betalactâmicos. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 1013-38. ISBN 85-6330801-6.

ANTIBIOTICOS BETALACTAMICOS; PENICILINA; AMINOPENICILINA; CEFALOSPORINA; CARBAPENENS; INIBIDORES DA BETALACTAMASE

8749/16820US=23-E / Câncer
Kato S, Ohno T. Cancer imaging and intracavitary brachytherapy for cervical cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 257-62. ISBN 978-90-481-2917-1.

CANCER DE IMAGEM; BRAQUITERAPIA INTRACAVITARIA; CANCER CERVICAL

8750/16820US=23-E / Câncer
Greimel E. Cervical cancer: methods for assessing the quality of life. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 263-73. ISBN 978-90-481-2917-1.

CANCER DE COLO UTERINO; CANCER DE COLO UTERINO. QUALIDADE DE VIDA

8751/16820US=23-E / Câncer
Lin LL, Grigsby PW. Cervical cancer: positron emission tomography and positron emission tomography/computed tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 275-84. ISBN 978-90-481-2917-1.

CANCER CERVICAL; TOMOGRAFIA POR EMISSAO DE POSITRONS; TOMOGRAFIA POR EMISSAO DE POSITRONS/TOMOGRAFIA COMPUTADORIZADA

8752/16820US=1-A / Farmacologia
Chambers HF. Inibidores da síntese de proteínas e agentes antibacterianos diversos. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 1055-81. ISBN 85-6330801-6.

AGENTES MICROBIANOS; TETRACICLINA; CLORANFENICOL; ERITROMICINA; CLARITROMICINA; AZITROMICINA; CETOLIDEOS; TELITROMICINA; CLINDAMICINA; QUINUPRISTINA; DALFOPRISTINA; LINEZOLIDA; VANCOMICINA; MUPIROCINA

8753/16820US=23-E / Câncer
Ino K, Yamatomoto E, Shibata K, Kajiyama H, Nawa A, Kikkawa F. Cervical cancer: positron emission tomography and positron emission tomography/computed tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 275-84. ISBN 978-90-481-2917-1.

CANCER CERVICAL; TOMOGRAFIA POR EMISSAO DE POSITRONS; TOMOGRAFIA POR EMISSAO DE POSITRONS/TOMOGRAFIA COMPUTADORIZADA

8754/16820US=23-E / Câncer
Ino K, Yamatomoto E, Shibata K, Kajiyama H, Nawa A, Kikkawa F. Endometrial cancer: indoleamine 2,3-dioxygenase as a prognostic indicator. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 285-95. ISBN 978-90-481-2917-1.

CANCER DE ENDOMETRIO; 2,3-DIOXIGENASE INDOLEAMINA; INDICADOR DE PROGNOSTICO

8755/16820US=23-E / Câncer
Rübben A. Neurofibromatosis type 1-associated malignant melanoma: molecular evidence of inactivation of the NF1 gene. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 301-9. ISBN 978-90-481-2917-1.

NEUROFIBROMATOSE TIPO 1; MELANOMA MALIGNO; EVIDENCIA MOLECULAR DE INATIVACAO DO GENE NF1

8756/16820US=23-E / Câncer
Gheysens O, Mottaghy FM. Malignant melanoma: localisation and characterization using fluorodeoxyglucose-positron emission tomography/computed tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 311-22. ISBN 978-90-481-2917-1.

MELANOMA MALIGNO; FLUORODESOXIGLICOSE POR EMISSAO DE POSITRONS; TOMOGRAFIA COMPUTADORIZADA

8757/16820US=1-A / Farmacologia
Petri WA Jr. Quimioterapia da tuberculose, complexo mycobacterium avium e hanseníase. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 1083-102. ISBN 85-6330801-6.

TUBERCULOSE. TRATAMENTO FARMACOLOGICO; IONIAZIDA; RIFAMICINA; ESTREPTOMICINA; PIRAZINAMIDA; QUINOLONA; LINEZOLIDA; INTERFERONA-Y; ETIONAMIDA; ACIDO AMINOSSALICILICO; CICLOSSERINA; COMPLEXO MYCOBACTERIUM AVIUM. TRATAMENTO FARMACOLOGICO; RIFABUTINA; MACROLIDIOS; QUINOLONA; HANSENIASE. TRATAMENTO FARMACOLOGICO; SULFONAS; RIFAMPICINA; CLOFAZIMINA

8758/16820US=23-E / Câncer
Roesch A, Landthaler M, Vogt T. Malignant melanoma versus deep penetrating nevus:diagnostic and prognostic immunohistochemistry of dipeptidy1 peptidase IV (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 323-31. ISBN 978-90-481-2917-1.

MELANOMA MALIGNO; IMUNO-HISTOQUIMICA; DIPEPTIDE; PEPTIDASE IV; DIPEPTIDIL PEPTIDASE-4; DPP4

8759/16820US=23-E / Câncer
Hafner C. Nonmelanoma skin cancer use of Epha1 receptor as a prognostic marker. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 333-40. ISBN 978-90-481-2917-1.

CANCER DE PELE; EPHA1 RECEPTOR

8760/16820US=23-E / Câncer
Fiegl M, Mayer J. Pretreated chronic lymphocytic leukemia: use of alemtuzumab. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 343-58. ISBN 978-90-481-2917-1.

LEUCEMIA CRONICA. TRATAMENTO; LINFOCITICA; TRATAMENTO COM USO DE ALEMTUZUMAB

Primeira | Anterior | Próxima | Última